ES2544874T3 - Dispositivo de administración de insulina - Google Patents
Dispositivo de administración de insulina Download PDFInfo
- Publication number
- ES2544874T3 ES2544874T3 ES11833366.5T ES11833366T ES2544874T3 ES 2544874 T3 ES2544874 T3 ES 2544874T3 ES 11833366 T ES11833366 T ES 11833366T ES 2544874 T3 ES2544874 T3 ES 2544874T3
- Authority
- ES
- Spain
- Prior art keywords
- controller
- zone
- blood glucose
- insulin delivery
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract description 20
- 102000004877 Insulin Human genes 0.000 title abstract description 10
- 108090001061 Insulin Proteins 0.000 title abstract description 10
- 229940125396 insulin Drugs 0.000 title abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 15
- 239000008103 glucose Substances 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 208000013016 Hypoglycemia Diseases 0.000 abstract description 4
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 4
- 201000001421 hyperglycemia Diseases 0.000 abstract description 3
- 238000005259 measurement Methods 0.000 abstract 2
- 238000009826 distribution Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 description 4
- 238000005457 optimization Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39239910P | 2010-10-12 | 2010-10-12 | |
| US392399P | 2010-10-12 | ||
| PCT/US2011/056022 WO2012051344A2 (en) | 2010-10-12 | 2011-10-12 | Maintaining multiple defined physiological zones using model predictive control |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2544874T3 true ES2544874T3 (es) | 2015-09-04 |
Family
ID=45938960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11833366.5T Active ES2544874T3 (es) | 2010-10-12 | 2011-10-12 | Dispositivo de administración de insulina |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9700708B2 (enExample) |
| EP (1) | EP2628115B1 (enExample) |
| JP (1) | JP6062859B2 (enExample) |
| CA (1) | CA2816388C (enExample) |
| DK (1) | DK2628115T3 (enExample) |
| ES (1) | ES2544874T3 (enExample) |
| WO (1) | WO2012051344A2 (enExample) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| US9757510B2 (en) | 2012-06-29 | 2017-09-12 | Animas Corporation | Method and system to handle manual boluses or meal events for closed-loop controllers |
| US9486578B2 (en) * | 2012-12-07 | 2016-11-08 | Animas Corporation | Method and system for tuning a closed-loop controller for an artificial pancreas |
| US9907909B2 (en) | 2012-12-20 | 2018-03-06 | Animas Corporation | Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas |
| WO2014110541A1 (en) * | 2013-01-14 | 2014-07-17 | The Regents Of University Of California | Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications |
| US9517306B2 (en) | 2013-03-15 | 2016-12-13 | Animas Corporation | Method and system for closed-loop control of an artificial pancreas |
| US9795737B2 (en) | 2013-03-15 | 2017-10-24 | Animas Corporation | Method and system for closed-loop control of an artificial pancreas |
| ES2671001T3 (es) | 2013-03-15 | 2018-06-04 | Animas Corporation | Modelo de tiempo-acción de insulina |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| US9474855B2 (en) | 2013-10-04 | 2016-10-25 | Animas Corporation | Method and system for controlling a tuning factor due to sensor replacement for closed-loop controller in an artificial pancreas |
| US9861747B2 (en) | 2013-12-05 | 2018-01-09 | Lifescan, Inc. | Method and system for management of diabetes with a glucose monitor and infusion pump to provide feedback on bolus dosing |
| GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
| CA2957432C (en) * | 2014-08-06 | 2017-07-25 | Regents Of The University Of California | Moving-horizon state-initializer for control applications |
| EP3733227B1 (en) | 2015-02-18 | 2024-05-01 | Insulet Corporation | Fluid delivery and infusion devices |
| US10275573B2 (en) | 2016-01-13 | 2019-04-30 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
| WO2017123703A2 (en) | 2016-01-14 | 2017-07-20 | Bigfoot Biomedical, Inc. | Occlusion resolution in medication delivery devices, systems, and methods |
| EP4545005A3 (en) | 2016-01-14 | 2025-07-02 | Insulet Corporation | Adjusting insulin delivery rates |
| FR3047098B1 (fr) * | 2016-01-21 | 2018-05-25 | Voluntis | Gestion de l'equilibre glycemique d'un patient diabetique |
| WO2017136155A1 (en) * | 2016-02-05 | 2017-08-10 | Animas Corporation | Visualization and analysis tool for a drug delivery system |
| US12383166B2 (en) | 2016-05-23 | 2025-08-12 | Insulet Corporation | Insulin delivery system and methods with risk-based set points |
| EP3515535A1 (en) | 2016-09-23 | 2019-07-31 | Insulet Corporation | Fluid delivery device with sensor |
| WO2018111928A1 (en) | 2016-12-12 | 2018-06-21 | Mazlish Bryan | Alarms and alerts for medication delivery devices and related systems and methods |
| US10500334B2 (en) | 2017-01-13 | 2019-12-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10583250B2 (en) | 2017-01-13 | 2020-03-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| WO2018132723A1 (en) | 2017-01-13 | 2018-07-19 | Mazlish Bryan | Insulin delivery methods, systems and devices |
| WO2018132765A1 (en) | 2017-01-13 | 2018-07-19 | Mazlish Bryan | Insulin delivery methods, systems and devices |
| US10881793B2 (en) | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10758675B2 (en) | 2017-01-13 | 2020-09-01 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US11497851B2 (en) | 2017-03-31 | 2022-11-15 | Lifescan Ip Holdings, Llc | Maintaining maximum dosing limits for closed loop insulin management systems |
| US10729849B2 (en) | 2017-04-07 | 2020-08-04 | LifeSpan IP Holdings, LLC | Insulin-on-board accounting in an artificial pancreas system |
| US11147920B2 (en) | 2017-04-18 | 2021-10-19 | Lifescan Ip Holdings, Llc | Diabetes management system with automatic basal and manual bolus insulin control |
| CN116531603A (zh) | 2017-05-05 | 2023-08-04 | 伊莱利利公司 | 生理葡萄糖的闭环控制 |
| EP3438858A1 (en) | 2017-08-02 | 2019-02-06 | Diabeloop | Closed-loop blood glucose control systems and methods |
| CA3085930A1 (en) | 2017-12-21 | 2019-06-27 | Eli Lilly And Company | Closed loop control of physiological glucose |
| JP6938363B2 (ja) * | 2017-12-27 | 2021-09-22 | オムロンヘルスケア株式会社 | 情報処理装置、生体情報測定装置、方法及びプログラム |
| USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
| US11147919B2 (en) | 2018-04-23 | 2021-10-19 | Medtronic Minimed, Inc. | Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system |
| US11158413B2 (en) * | 2018-04-23 | 2021-10-26 | Medtronic Minimed, Inc. | Personalized closed loop medication delivery system that utilizes a digital twin of the patient |
| JP7124120B2 (ja) | 2018-05-04 | 2022-08-23 | インスレット コーポレイション | 制御アルゴリズムベースの薬物送達システムのための安全制約 |
| US12020797B2 (en) | 2018-06-22 | 2024-06-25 | Ypsomed Ag | Insulin and pramlintide delivery systems, methods, and devices |
| CN112789070A (zh) | 2018-09-28 | 2021-05-11 | 英赛罗公司 | 人造胰腺系统的活动模式 |
| EP3864668A1 (en) | 2018-10-11 | 2021-08-18 | Insulet Corporation | Event detection for drug delivery system |
| USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
| US11986629B2 (en) | 2019-06-11 | 2024-05-21 | Medtronic Minimed, Inc. | Personalized closed loop optimization systems and methods |
| US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
| US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
| EP4657456A2 (en) | 2019-12-06 | 2025-12-03 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
| US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
| WO2021141941A1 (en) | 2020-01-06 | 2021-07-15 | Insulet Corporation | Prediction of meal and/or exercise events based on persistent residuals |
| EP4100958A1 (en) | 2020-02-03 | 2022-12-14 | Insulet Corporation | Use of fuzzy logic in predicting user behavior affecting blood glucose concentration |
| US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
| US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
| US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
| US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
| US12495994B2 (en) | 2020-02-20 | 2025-12-16 | Insulet Corporation | Meal bolus subcategories in model based insulin therapy |
| US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
| WO2022020197A1 (en) | 2020-07-22 | 2022-01-27 | Insulet Corporation | Open-loop insulin delivery basal parameters based on insulin delivery records |
| US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
| US12128215B2 (en) | 2020-09-30 | 2024-10-29 | Insulet Corporation | Drug delivery device with integrated optical-based glucose monitor |
| WO2022072618A1 (en) | 2020-09-30 | 2022-04-07 | Insulet Corporation | Secure wireless communications between a glucose monitor and other devices |
| US11160925B1 (en) | 2021-01-29 | 2021-11-02 | Insulet Corporation | Automatic drug delivery system for delivery of a GLP-1 therapeutic |
| EP4305636A1 (en) | 2021-03-10 | 2024-01-17 | Insulet Corporation | A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions |
| US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
| US12496398B2 (en) | 2021-05-28 | 2025-12-16 | Insulet Corporation | Threshold based automatic glucose control response |
| US12406760B2 (en) | 2021-06-07 | 2025-09-02 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
| US12514980B2 (en) | 2021-06-30 | 2026-01-06 | Insulet Corporation | Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase |
| US12521486B2 (en) | 2021-07-16 | 2026-01-13 | Insulet Corporation | Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems |
| US11738144B2 (en) | 2021-09-27 | 2023-08-29 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
| US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
| CA3275991A1 (en) | 2023-01-06 | 2024-07-11 | Insulet Corporation | Automatic or manual administration of meal boluses with subsequent automatic relaxation of safety constraints |
| US20250166810A1 (en) * | 2023-11-22 | 2025-05-22 | Cilag Gmbh International | Data streams multi-system interaction |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3251224B2 (ja) * | 1998-02-26 | 2002-01-28 | 勲 長澤 | 病棟情報システム |
| US8423113B2 (en) * | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US9135402B2 (en) * | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US8369919B2 (en) * | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US7806854B2 (en) * | 2005-05-13 | 2010-10-05 | Trustees Of Boston University | Fully automated control system for type 1 diabetes |
| US9392969B2 (en) * | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
| US8721584B2 (en) * | 2006-11-02 | 2014-05-13 | The University Of North Carolina At Chapel Hill | Methods and systems for determining an intravenous insulin infusion rate to correct hyperglycemia of a patient, to maintain euglycemia of a patient, and to prevent hypoglycemia of a patient |
| US20080154513A1 (en) * | 2006-12-21 | 2008-06-26 | University Of Virginia Patent Foundation | Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes |
| CN101663059A (zh) * | 2007-03-19 | 2010-03-03 | 梅丁格有限公司 | 药物输送设备中选择单次剂量的用户接口 |
| US8221345B2 (en) * | 2007-05-30 | 2012-07-17 | Smiths Medical Asd, Inc. | Insulin pump based expert system |
| WO2009139846A1 (en) * | 2008-05-12 | 2009-11-19 | Department Of Veterans Affairs | Automated system and method for diabetes control |
| US9317657B2 (en) * | 2008-11-26 | 2016-04-19 | University Of Virginia Patent Foundation | Method, system, and computer program product for tracking of blood glucose variability in diabetes |
| JP5661651B2 (ja) * | 2009-02-25 | 2015-01-28 | ユニバーシティ オブ ヴァージニア パテント ファウンデーション | 低血糖のリスク査定およびなだらかなインスリン放出の減少による、ｃｇｍに基づいた低血糖の予防 |
-
2011
- 2011-10-12 JP JP2013533983A patent/JP6062859B2/ja active Active
- 2011-10-12 WO PCT/US2011/056022 patent/WO2012051344A2/en not_active Ceased
- 2011-10-12 CA CA2816388A patent/CA2816388C/en active Active
- 2011-10-12 ES ES11833366.5T patent/ES2544874T3/es active Active
- 2011-10-12 EP EP11833366.5A patent/EP2628115B1/en active Active
- 2011-10-12 DK DK11833366.5T patent/DK2628115T3/en active
-
2013
- 2013-04-02 US US13/854,963 patent/US9700708B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2816388C (en) | 2016-12-06 |
| US20130231642A1 (en) | 2013-09-05 |
| JP6062859B2 (ja) | 2017-01-18 |
| US9700708B2 (en) | 2017-07-11 |
| EP2628115B1 (en) | 2015-06-03 |
| CA2816388A1 (en) | 2012-04-19 |
| EP2628115A2 (en) | 2013-08-21 |
| WO2012051344A2 (en) | 2012-04-19 |
| JP2013542011A (ja) | 2013-11-21 |
| EP2628115A4 (en) | 2014-04-23 |
| DK2628115T3 (en) | 2015-08-24 |
| HK1182496A1 (en) | 2013-11-29 |
| WO2012051344A3 (en) | 2012-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2544874T3 (es) | Dispositivo de administración de insulina | |
| US11026640B1 (en) | Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered | |
| US11883208B2 (en) | Machine learning-based system for estimating glucose values based on blood glucose measurements and contextual activity data | |
| US10080840B2 (en) | Control unit for infusion pump units, including a controlled intervention unit | |
| US12478732B2 (en) | Alert management based on sleeping status | |
| US10517535B2 (en) | Method for controlling wearable device and wearable device | |
| US10772503B2 (en) | Wireless analyte monitoring | |
| ES2656212T3 (es) | Sistema para la detección y control de la hipoglucemia | |
| KR102407564B1 (ko) | 생체 정보를 판단하는 전자 장치 및 이의 동작 방법 | |
| US20220361823A1 (en) | Wearable blood pressure biosensors, systems and methods for short-term blood pressure prediction | |
| ES2973033T3 (es) | Sensor implantable | |
| US20180369479A1 (en) | Artificial Pancreas Integrated CGM Architectures and Designs | |
| BR112016016468B1 (pt) | Sistema de monitoramento de saúde | |
| Ahmed et al. | Solar powered smart wearable health monitoring and tracking device based on GPS and GSM technology for children with autism | |
| JP2015202012A (ja) | 電源回路、電源システム、および携帯端末装置 | |
| Ata et al. | Model based control of artificial pancreas under meal disturbances | |
| AU2020304356B2 (en) | Systems and methods for detecting missed bolus doses | |
| Zhang et al. | Smart hydrogel sensors: advancing from highly sensitive detection to an integrated platform for miRNA diagnosis and treatment | |
| Lubecke | Wearable wireless electronics | |
| EP4613192A1 (en) | Blood glucose measurement method, electronic device, and system | |
| KR20170082919A (ko) | 수면 시간을 이동하는 전자 장치 및 그 제어 방법 | |
| Cerutti | Cardiovascular Variability Signals: Assessment of Autonomic Controlling Systems with Novel Application Tools | |
| UA87814U (uk) | Спосіб корекції фізіологічного і функціонального стану людини |